GeneMatrix Market Cap

GeneMatrix has a market cap or net worth of 41.50 billion as of April 28, 2026. Its market cap has decreased by -10.75% in one year.

Market Cap

41.50B

Enterprise Value

n/a

Revenue

4.72B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,035.00

Market Cap Chart

Since November 6, 2009, GeneMatrix's market cap has increased from 33.85B to 41.50B, an increase of 22.60%. That is a compound annual growth rate of 1.24%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	41.50B	-17.11%
Dec 30, 2025	50.07B	-9.74%
Dec 30, 2024	55.47B	-12.40%
Dec 28, 2023	63.32B	-23.43%
Dec 29, 2022	82.69B	-58.54%
Dec 30, 2021	199.45B	-62.10%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PeopleBio	34.89B
Seoulin Bioscience	57.11B
Protia	63.36B
Green Cross Medical Science	84.90B
HLB Panagene	99.35B
Cytogen	116.50B
Median Diagnostics	15.19B
Inventera	183.66B

Market Cap Rankings